Article
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies
23 Feb 2024
Abstract excerpt
The identification of clinically-relevant biomarkers is of upmost importance for the management of cancer, from diagnosis to treatment choices. We performed a pan-cancer analysis of the mitotic checkpoint budding uninhibited by benzimidazole 1 gene BUB1, in the attempt to ascertain its diagnostic and prognostic values, specifically in the context of drug response. BUB1 was found to be overexpressed in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
